 | UroGen Pharma Ltd. | |||
| NasdaqGM : URGN || Location: United States | ||||
$8.32+0.1 (+1.22%) |
0.01 M | 8.24 - 8.5385 | ||
| Last Updated:09/30/2022 16:49 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| Aug. 31, 2022 | 1.412 M |
| Aug. 15, 2022 | 1.461 M |
| July 29, 2022 | 1.475 M |
| July 15, 2022 | 1.523 M |
| June 30, 2022 | 1.703 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2022 | -1.27 | -1.18 | 7.10% |
| 03/31/2022 | -1.33 | -1.25 | 6.00% |
| 12/31/2021 | -1.17 | -1.27 | -8.50% |
| 09/30/2021 | -1.29 | -1.35 | -4.70% |
| 06/30/2021 | -1.13 | -1.17 | -3.50% |
URGN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 22.741M | Shares Float | 18.967M |
| Short Float | 1.412M | Market Cap | 186.93M |
| Institution ownership | 76.40% | Insider ownership | 9.699% |
| Earnings Date | 11/14/2022 | Cash Per Share | ? |
| Trailing EPS | -5.05 | Forward EPS | -2.88 |